HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arylalkylamine N-acetyltransferase (AANAT) is expressed in astrocytes and melatonin treatment maintains AANAT in the gerbil hippocampus induced by transient cerebral ischemia.

Abstract
Melatonin is synthesized from serotonin by the action of arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase. In this study, we observed cellular changes of arylalkylamine N-acetyltransferase (EC 2.3.1.87; AANAT) in the hippocampal CA1 region at various time points after ischemia/reperfusion. In vehicle-treated sham group, AANAT immunoreaction was detected in pyramidal neurons of the CA1 region. AANAT immunoreactivity in the neurons was highest 2 days and disappeared from 4 days after ischemia/reperfusion. From 3 days after ischemia/reperfusion, AANAT immunoreaction was expressed in astrocytes in the strata oriens and radiatum of the CA1 region. AANAT protein and mRNA levels were significantly increased 2 days after ischemia/reperfusion, and markedly decreased from 5 days after ischemia/reperfusion. The repeated administration of melatonin (10 mg/kg, i.p.) 3 times (once a day) to gerbils before ischemia/reperfusion significantly reduced ischemia-induced hyperactivity as well as neuronal death compared to those in the vehicle-treated ischemia group. Melatonin treatment also maintained AANAT immunoreactivity and its protein levels in the CA1 region after ischemia/reperfusion. These results suggest that the reduction of AANAT in ischemic CA1 region is associated with delayed neuronal death following transient ischemia, and melatonin treatment shows neuroprotection with maintenance of AANAT levels in the ischemic CA1 region.
AuthorsOk Kyu Park, Ki-Yeon Yoo, Choong Hyun Lee, Jung Hoon Choi, In Koo Hwang, Jun Hong Park, Young-Guen Kwon, Young-Myeong Kim, Moo-Ho Won
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 294 Issue 1-2 Pg. 7-17 (Jul 15 2010) ISSN: 1878-5883 [Electronic] Netherlands
PMID20488463 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 Elsevier B.V. All rights reserved.
Chemical References
  • Glial Fibrillary Acidic Protein
  • Neuroprotective Agents
  • RNA, Messenger
  • Arylalkylamine N-Acetyltransferase
  • Melatonin
Topics
  • Animals
  • Arylalkylamine N-Acetyltransferase (metabolism)
  • Astrocytes (drug effects, enzymology, metabolism)
  • CA1 Region, Hippocampal (drug effects, enzymology, metabolism)
  • Cell Death (drug effects)
  • Gerbillinae
  • Glial Fibrillary Acidic Protein (metabolism)
  • Ischemic Attack, Transient (drug therapy, enzymology, metabolism)
  • Melatonin (administration & dosage, therapeutic use)
  • Motor Activity (drug effects)
  • Neurons (drug effects, enzymology, metabolism)
  • Neuroprotective Agents (administration & dosage, therapeutic use)
  • Pyramidal Cells (drug effects, enzymology, metabolism)
  • RNA, Messenger (metabolism)
  • Reperfusion Injury (drug therapy, enzymology, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: